CLAIM #33987 · Johnson & Johnson (JNJ) · 2024Q4 earnings call · Jan 22, 2025 · due Dec 31, 2027
“We're confident in our expectations communicated at the EBR. And as a reminder, we expect our end markets to grow between 5% and 7% on a weighted average basis between 22% and 27%.”
Joseph Wolk · CFO
PENDING
graded after results covering Dec 31, 2027 are reported
How to check this claim
Look at: Weighted-average growth rate of company's end markets, as referenced from the Enterprise Business Review (EBR) targets
It came true if: Weighted average end-market growth between 5% and 7%, cumulative/annualized through the stated period, based on company-disclosed figures
Where: Company management commentary (earnings calls, investor presentations, EBR follow-up disclosures) through 2027
Verify independently
SEC filings for JNJ ↗ · Claim quote is verbatim from the 2024Q4 earnings call.